New Research Poster Presentation 2.24
Efficacy and Safety of High-Dose Folinic Acid in Autism Spectrum Disorder: Open Label Follow-Up of a Randomized Controlled Trial
Thursday, October 29, 2015 10:00 AM
Leanna Delhey, BA, Padiatrics, Arkansas Children's Hospital Research Institute, Little Rock, AR
John Slattery, BA, 3Department of Pediatrics, Arkansas Children's Hospital Research Institute, Little Rock, AR
Fnu Deepmala, MD, University of Arkansas for Medical Sciences, Little Rock, AR
Billy Furgerson, PharmD, Arkansas Children's Hospital, Little Rock, AR
Teru Strickland, PharmD, Arkansas Children's Hospital, Little Rock, AR
Marie Tippett, BA, Pediatrics, Arkansas Children's Hospital Research Institute, Little Rock, AR
Angela Sailey, PhD, Arkansas Children's Hospital, Little Rock, AR
Rebecca Wynne, MS, Pediatrics, Arkansas Children's Hospital, Little Rock, AR
Shannon Rose, PhD, Pediatrics, Arkansas Children's Hospital Research Institute, Little Rock, AR
Stepan Melnyk, MD, Pediatrics, Arkansas Children's Hospital Research Institute, Little Rock, AR
S. Jill James, PhD, Arkansas Children's Hospital, Little Rock, AR
Jeffery Sequeira, MS, Medicine, SUNY Downstate Medical Center, Brooklyn, NY
Edward Quadros, PhD, Medicine, SUNY Downstate Medical Center, Brooklyn, NY
Richard Frye, MD, PhD, Arkansas Children's Hospital Research Institute, Little Rock, AR
